Vigabatrin Therapy

Vigabatrin Therapy is a pharmacotherapeutic intervention that involves the administration of vigabatrin, an irreversible GABA transaminase inhibitor, to selectively enhance central nervous system GABAergic neurotransmission for the management of refractory pediatric epilepsy syndromes, notably infantile spasms and tuberous sclerosis complex-associated seizures.

531

Publications

26.7K

Citations

2.1K

Authors

640

Institutions

Publications per year

2017–2026

44

Authors

2.1K

  1. JP
    J. P. Mumford

    University of Pavia, Italy

    17 publications · 1.7K citations

    17

    h-index

  2. CC
    Catherine Chiron

    Inserm, France

    16 publications · 1.5K citations

    15

    h-index

  3. OD
    Olivier Dulac

    Inserm, France

    13 publications · 1.3K citations

    12

    h-index

  4. PR
    Paavo Riekkinen

    University of Eastern Finland, Finland

    13 publications · 420 citations

    12

    h-index

  5. JW
    Josemir W. Sander

    University College London, United Kingdom

    11 publications · 539 citations

    11

    h-index

1–5 of 2.1K

Venues

  1. Epilepsia

    85 publications · 4.9K citations

    43

    h-index

  2. Neurology

    29 publications · 2.6K citations

    25

    h-index

  3. Epilepsy Research

    33 publications · 1.7K citations

    22

    h-index

  4. Journal of Child Neurology

    JCN · 26 publications · 1.2K citations

    21

    h-index

  5. British Journal of Clinical Pharmacology

    BJCP · 22 publications · 1.2K citations

    19

    h-index

1–5